We have observed
6 EP applications
Jessica Ann Kershaw
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after March 22, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS
HYDANTOIN DERIVATIVES AS KV3 INHIBITORS
TRIAZOLES AS KV3 INHIBITORS
METHOD OF TREATING IRON DEFICIENCY ANEMIA
COATING FOR SUBSTRATE
NOVEL DRUG FORMULATION